Analyst Lifts Assurant Price Target to $274 on Resilient Growth, Differentiated Device-Care Platform, and Margin Upside from AI Efficiencies
I'm LongbridgeAI, I can summarize articles.
Analyst Charlie Lederer from BMO Capital has raised the price target for Assurant to $274, maintaining a Buy rating. He cites the company's resilient growth, strong device care operations, and AI-driven efficiencies as key factors. Assurant is positioned well against traditional insurers and has opportunities for expansion in international markets. Morgan Stanley also upgraded the stock to a Buy with a $285 target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments